Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2012
07/18/2012CN101217965B Glucose uptake modulator and method for treating diabetes or diabetic complications
07/18/2012CN101199318B Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use
07/18/2012CN101108000B Addition-application method of functional properties fat planting food mixture
07/17/2012US8222405 Phenylalanine derivatives
07/17/2012US8222384 Modified and stabilized GDF propeptides and uses thereof
07/17/2012US8222277 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/17/2012US8222238 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
07/17/2012US8222231 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
07/17/2012US8222217 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
07/17/2012US8221786 Pharmaceutical formulations containing an SGLT2 inhibitor
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012CA2492659C 6-(3-pyridyl-methylamino)purine derivatives and their use as antiproliferative agents
07/17/2012CA2488373C N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris
07/17/2012CA2451704C Fortified rice bran food product and method for promoting cardiovascular health
07/17/2012CA2451028C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
07/17/2012CA2418984C Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof
07/17/2012CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof
07/17/2012CA2355976C Vascular endothelial cell growth factor antagonists and uses thereof
07/12/2012WO2012094636A2 Chemosensory receptor ligand-based therapies
07/12/2012WO2012094462A2 Heterocyclic compounds for the inhibition of pask
07/12/2012WO2012094293A1 Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2
07/12/2012WO2012094081A2 System and method for identifying and applying peripheral treatment mechanisms for disease
07/12/2012WO2012093809A2 New bicyclic compound for modulating g protein-coupled receptors
07/12/2012WO2012093229A1 Food composition made of an algae extract for treating and/or preventing diabetic retinopathy
07/12/2012WO2012093169A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
07/12/2012WO2012093068A1 A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide
07/12/2012WO2012092760A1 Method for obtaining strains highly expressing lipase and use of lipase obtained
07/12/2012WO2012058276A3 Methods and materials for reducing mutiple risk factors associated with the metabolic syndrom
07/12/2012WO2012048214A9 Use of hyaluronan for promoting angiogenesis
07/12/2012WO2012030957A3 Non-hygroscopic salts of 5-ht2c agonists
07/12/2012US20120179090 Transmucosal delivery of therapeutic agents and methods of use thereof
07/12/2012US20120178820 Method for treating arthritis
07/12/2012US20120178813 Lipid-lowering antidiabetic agent
07/12/2012US20120178809 Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof
07/12/2012US20120178808 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
07/12/2012US20120178801 Compositions and its use in treating obesity or inducing weight loss
07/12/2012US20120178799 Energy beverage with creatine and caffeine combination
07/12/2012US20120178789 Novel pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use
07/12/2012US20120178784 Use Of Inhibitors Of The Renin-Angiotensin System
07/12/2012US20120178781 Kappa opioid receptor ligands
07/12/2012US20120178778 Pyrazolopyridines
07/12/2012US20120178776 Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mglur5 modulators
07/12/2012US20120178774 Toll-like receptor modulators and uses thereof
07/12/2012US20120178765 Novel glucokinase activators and processes for the preparation thereof
07/12/2012US20120178759 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
07/12/2012US20120178750 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
07/12/2012US20120178748 Heteroaryl compounds and methods of use thereof
07/12/2012US20120178747 Compositions and methods for bone formation and remodeling
07/12/2012US20120178746 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
07/12/2012US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase
07/12/2012US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/12/2012US20120178734 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
07/12/2012US20120178729 Crystalline form i rosuvastatin zinc salt
07/12/2012US20120178721 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
07/12/2012US20120178718 Novel imidazolidine compounds as androgen receptor modulators
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
07/12/2012US20120178712 Phytochemical compositions including sesamin for anti-inflammatory, anti-cytokine storm, and other uses
07/12/2012US20120178701 Melanocortin Receptor-Specific Peptides
07/12/2012US20120178697 Compositions and methods for the inhibition of dishevelled proteins
07/12/2012US20120178687 Suspension formulations of insulinotropic peptides and uses thereof
07/12/2012US20120178685 Fgf21 mutants and uses thereof
07/12/2012US20120178681 Bipiperidinyl compounds, compositions, containing such compounds and methods of treatment
07/12/2012US20120178680 Glycoside derivatives and uses thereof
07/12/2012US20120178679 Fused aromatic ptp-ib inhibitors
07/12/2012US20120178678 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
07/12/2012US20120178677 Soft protease inhibitors, and pro-soft forms thereof
07/12/2012US20120178676 Pegylated c-peptide
07/12/2012US20120178675 Compositions And Methods For Modulating The Pharmacokinetics and Pharmacodynamics of Insulin
07/12/2012US20120178674 Mixture of non-digestible oligosaccharides for stimulating the immune system
07/12/2012US20120178673 Fat accumulation suppressor
07/12/2012US20120178672 Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis
07/12/2012US20120178670 Acylated glucagon analogues
07/12/2012US20120178668 Proteinaceous compounds and uses therefor
07/12/2012US20120178629 Apparatus and methods for preparing an emulsion
07/12/2012US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120177759 Compositions and methods for increasing lifespan and health span
07/12/2012US20120177754 Inhibitor of inflammatory conditions
07/12/2012US20120177752 Nutritional compositions including beta-hydroxy-beta-methylbutyrate
07/12/2012US20120177744 Method of using beta-hydroxy-beta-methylbutyrate for the treatment of cancer
07/12/2012US20120177740 Drug delivery formulation for controlling of initial burst and manufacturing method thereof
07/12/2012US20120177738 Green tea extracts of improved bioavailability
07/12/2012US20120177730 Chemosensory Receptor Ligand-Based Therapies
07/12/2012US20120177722 Lyaseenzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them
07/12/2012US20120177716 Methods for Making Controlled Delivery Devices Having Zero Order Kinetics
07/12/2012US20120177709 Low ph structured surfactant composition
07/12/2012US20120177704 Crystalline anti-human il-12 antibodies
07/12/2012US20120177701 Compositions comprising immunostimulatory nucleic acids and related methods
07/12/2012US20120177699 Preparation Method of Drug Loaded Emulsion
07/12/2012US20120177697 Excipients In Drug Delivery Vehicles
07/12/2012US20120177667 Metal Abstraction Peptide (MAP) Tag and Associated Methods
07/12/2012US20120177661 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor
07/12/2012US20120177660 Biomarkers and therapeutic targets for type 1 diabetes
07/12/2012US20120177655 Anti-human il-21 monoclonal antibodies
07/12/2012US20120177654 Method of treatment and agents useful for same
07/12/2012US20120177646 Fgf21 mutants and uses thereof
07/12/2012US20120177631 Composition for Health Promoting Compounds
07/12/2012US20120177629 Predigested Nutritional Formula
07/12/2012US20120177623 Compositions for Boosting Metabolism, Assisting Weight Loss, and Promoting Cardiovascular Health
07/12/2012US20120177602 Dissolution aids for oral peptide delivery comprising a biguanide
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 1298